Sepracor, HMR autoimmune/inflammation news

The U.S. Patent and Trademark Office (PTO) declared an interference between patents held by SEPR and HMR covering non-sedating antihistamines.

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE